Targeting the Immune System in Atherosclerosis: JACC State-of-the-Art Review. (2019)

First Author: Zhao TX
Attributed to:  Low dose interleukin (IL)-2 in patients with a recent acute coronary syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jacc.2018.12.083

PubMed Identifier: 30947923

Publication URI: http://europepmc.org/abstract/MED/30947923

Type: Journal Article/Review

Volume: 73

Parent Publication: Journal of the American College of Cardiology

Issue: 13

ISSN: 0735-1097